47,614 Shares in Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Acquired by D. E. Shaw & Co. Inc.
D. E. Shaw & Co. Inc. purchased a new stake in Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Free Report) during the fourth quarter, HoldingsChannel reports. The firm purchased 47,614 shares of the biotechnology company’s stock, valued at approximately $222,000. Several other hedge funds have also added to or reduced their stakes in the business. Regeneron Pharmaceuticals […]
D. E. Shaw & Co. Inc. purchased a new stake in Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Free Report) during the fourth quarter, HoldingsChannel reports. The firm purchased 47,614 shares of the biotechnology company’s stock, valued at approximately $222,000. Several other hedge funds have also added to or reduced their stakes in the business. Regeneron Pharmaceuticals […]
